transluminal coronary angioplasty

基本解釋

Objective To explore the protected effect of acute myocardial infarction with diabetic patients after emergency percutaneous transluminal coronary angioplasty(PTCA).
目的研究急診PTCA治療糖尿病并急性心肌梗死對(duì)患者心功能的保護(hù)作用。
CONCLUSION EGB may have some potential clinical implication in the prevention and treatment of atherosclerosis and restenosis after percutaneous transluminal coronary angioplasty.
結(jié)論EGB對(duì)于動(dòng)脈粥樣硬化形成及經(jīng)皮腔內(nèi)冠狀動(dòng)脈介入治療后再狹窄的防治可能具有應(yīng)用前景。
Objective To evaluate the clinical value of coronary artery bypass surgery (CABG) versus percutaneous transluminal coronary angioplasty(PTCA) by analysing revascularization status.
目的通過(guò)對(duì)冠狀動(dòng)脈旁路手術(shù)（CABG）和經(jīng)皮腔內(nèi)冠狀動(dòng)脈成形術(shù)（PTCA）的臨床療效的分析，評(píng)價(jià)兩者的臨床應(yīng)用價(jià)值。

percutaneous transluminal balloon coronary angioplasty 經(jīng)皮球囊擴(kuò)張冠狀動(dòng)脈血管成形
Percutenous transluminal coronary angioplasty 是經(jīng)皮冠狀動(dòng)脈成形術(shù)
pereutaneous transluminal coronary angioplasty 成形術(shù)
percutanueous transluminal coronary angioplasty 經(jīng)皮冠狀動(dòng)脈成形術(shù)
Percutanous transluminal coronary angioplasty 對(duì)經(jīng)皮冠狀動(dòng)脈腔內(nèi)成形術(shù);成形術(shù)

冠心病
Coronary artery disease is one of the primary diseases to endanger human health. Most patients with CAD can be effectually cured by convention medicines or percutaneous transluminal coronary angioplasty(PTCA) or coronary aorta bypass graft(CABG).
冠心病是嚴(yán)重危害人類健康的主要心血管疾病之一，近二、三十年來(lái)，隨著冠狀動(dòng)脈造影、冠狀動(dòng)脈成形術(shù)（percutaneous transluminal coronaryangioplasty，PTCA）和冠狀動(dòng)脈—主動(dòng)脈旁路移植術(shù)（coronary aorta bypassgraft，CABG）等新技術(shù)的開(kāi)展，大多數(shù)冠心病患者得到了積極的診治，但冠心病PTCA晚期再狹窄發(fā)生率在30％—50％，CABG移植血管的通暢率亦隨術(shù)后時(shí)間延長(zhǎng)而遞減，心肌缺血仍是難以解決的問(wèn)題。